Duane Nash - 13 Jun 2025 Form 4 Insider Report for IMMUNIC, INC. (IMUX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
16 Jun 2025, 17:00:19 UTC
Prior SEC filing
20 Jun 2025
Next SEC filing
18 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Duane Nash

Key filing fact

Duane Nash filed Form 4 for IMMUNIC, INC. (IMUX) on 16 Jun 2025.

Key facts

  • This page summarizes Duane Nash's Form 4 filing for IMMUNIC, INC. (IMUX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 16 Jun 2025, 17:00.

Change

  • Previous filing in this sequence was filed on 20 Jun 2025.
  • Current net transaction value: +$16,694.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001591098 Primary reporting owner

Nash Duane

Relationship
Executive Chairman, Director
Address
1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK
Signature
/s/ Duane Nash
Signature date
16 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMUX transaction

Common Stock

Purchase

Transaction value
$16,694
Shares
+20,000
Change %
+125%
Price
$0.8347
Shares after
36,032
Date
13 Jun 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.83 to $0.84. The Reporting Person (RP) undertakes to provide to the Issuer, any securityholder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .